Back to ALL Research Publications
Research Category: Wound Sampling, Chronic Wounds
Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers
References
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario Canada.
2MolecuLight, Inc., Toronto, Ontario Canada.
3Hyperbaric Medicine, Judy Dan Research & Treatment Centre, Toronto, Ontario Canada.
4Department of Dermatology, Toronto Western Hospital, University Health Network, Toronto, Ontario Canada.
5Department of Biostatistics, University Health Network, Toronto, Ontario Canada.
6Department of Medical Biophysics, University of Toronto, Toronto, Ontario Canada.
7Techna Institute, Toronto, Ontario Canada.
Ready to see the difference?
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
Global
USA
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.
References
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario Canada.
2MolecuLight, Inc., Toronto, Ontario Canada.
3Hyperbaric Medicine, Judy Dan Research & Treatment Centre, Toronto, Ontario Canada.
4Department of Dermatology, Toronto Western Hospital, University Health Network, Toronto, Ontario Canada.
5Department of Biostatistics, University Health Network, Toronto, Ontario Canada.
6Department of Medical Biophysics, University of Toronto, Toronto, Ontario Canada.
7Techna Institute, Toronto, Ontario Canada.